About Index Trending news
Analyze
Pricing
VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.
I work here Suggest edits
More info

Elsewhere

Also headquartered in Seattle

Amazon Amazon GeekWire GeekWire Zillow Zillow Starbucks Starbucks Redfin Redfin Tableau Tableau Seattle Seattle Wagon Wagon Startup Weekend Startup Weekend Bungie Bungie

Companies in the same industry

Tricida, Inc. Tricida, Inc. Oculis Oculis Euclises Pharmaceuticals Euclises Pharmaceuticals Genialis Genialis Esperion Therapeutics Esperion Therapeutics RxAdvance RxAdvance Strongbridge Biopharma Strongbridge Biopharma ApoGen Biotechnologies ApoGen Biotechnologies Coronado Biosciences Coronado Biosciences Avro Life Science Avro Life Science

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
Latest funding
Venture capital (Series B)
$50,600,000
Celgene, ARCH Venture Partners, Frazier Healthcare Partners, +2
Employees

Team size

10+
Locations
HQ
Seattle, United States
Headquarters
Puget Sound Business Journal , sec

Seattle biopharma startup lands $19.3M in venture funding for cancer research

VentiRx Pharmaceuticals
VentiRx Pharmaceuticals